Product logins

Find logins to all Clarivate products below.


Kimon Kotronis

Director​, Technology Consulting

A medical doctor and avid technologist, Kimon has over 15 years of experience providing technology advisory and consultancy services to the Healthcare and Life Sciences industry, designing, developing and delivering technology solutions and systems to most of the top 20 Pharmaceutical companies. With a career spanning all aspects of the technology and data value chain in global life sciences companies and public and private healthcare organizations, he uniquely combines technology and digital transformation leadership through the creation of high performing Agile teams with domain knowledge and data management and governance skills.​

As a Director in the Technology Consulting team, Kimon leads architecture and development of custom solutions that leverage Clarivate data, integrating it with third party sources and customers’ own datasets to derive unique insights using intelligent visualizations, natural language processing, data analytics and AI technologies. ​

Kimon has written about and presented to international conferences on the challenges of data harmonization and digital product development for the generation of actionable insights in highly regulated environments. He has a MD from the Aristotle University of Thessaloniki, Greece, a MSc in Health Informatics from City University, London and a MBA from Bayes Business School, London. ​


arrow_forward
Get in touch with Kimon

Latest news

News September 22, 2026
Clarivate to Report Third Quarter 2026 Results on November 3, 2026

London, U.K., September 22, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the third…

News September 17, 2026
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) (“Clarivate”), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), has commenced a…

News September 17, 2026
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advances London, U.K. September 17, 2026: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence,…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.